Sky Labs Raises KRW 20.7 Billion in Series C Funding

Picture of the CART BP Product

Sky Labs, a Seoul, South Korea-based healthcare startup, raised KRW 20.7 Billion in Series C funding.

The round, which brought the total amount to KRW 54.8 Billion, saw participation from Korea Development Bank (KDB), K2 Investment Partners, Devsiters Ventures, SJG Partners, and Openwater Investment.

The company intends to use the funds to expand operations and its business reach.

Led by CEO Jack, Lee, Sky Labs is a preventive healthcare company aiming to transform conventional hospital centric care, into patient centric care with continuous monitoring in daily lives. Its ‘CART BP’ is a ring-type cuffless continuous blood pressure monitor, that enables continuous blood pressure measurement and monitoring 24/7. CART BP also tracks how lifestyle habits, such as sleep and stress management, exercising, drinking, and reactions to taking blood pressure pills, can impact blood pressure levels. By doing so, it helps hypertension patients manage their blood pressure levels and contributes to the prevention of cardiovascular disease.

Distribution of ‘CART BP,’ a ring-type cuffless blood pressure monitor that enables continuous blood pressure measurement and monitoring 24/7, will be fully launched to hospitals and clinics across Korea through a distribution agreement signed with Daewoong Pharmaceutical for the Korean market